Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Matthew N Svalina
Affiliation
University of Colorado Anschutz Medical Campus
ORCID
Career Start Year
2013
Papers
20
H Index
10
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36969493
From circuits to behavior: Amygdala dysfunction in fragile X syndrome.
Front Integr Neurosci
2023
36969493
From circuits to behavior: Amygdala dysfunction in fragile X syndrome.
Front Integr Neurosci
2023
35970562
Basolateral Amygdala Hyperexcitability Is Associated with Precocious Developmental Emergence of Fear-Learning in Fragile X Syndrome.
J Neurosci
2022
35970562
Basolateral Amygdala Hyperexcitability Is Associated with Precocious Developmental Emergence of Fear-Learning in Fragile X Syndrome.
J Neurosci
2022
33893168
Hyperexcitability and Loss of Feedforward Inhibition Contribute to Aberrant Plasticity in the <i>Fmr1</i>KO Amygdala.
eNeuro
2021
33893168
Hyperexcitability and Loss of Feedforward Inhibition Contribute to Aberrant Plasticity in the <i>Fmr1</i>KO Amygdala.
eNeuro
2021
31054580
Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Skelet Muscle
2019
31741706
Volasertib preclinical activity in high-risk hepatoblastoma.
Oncotarget
2019
31208434
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
BMC Cancer
2019
31113472
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Skelet Muscle
2019
31054580
Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Skelet Muscle
2019
31741706
Volasertib preclinical activity in high-risk hepatoblastoma.
Oncotarget
2019
31208434
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
BMC Cancer
2019
31113472
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Skelet Muscle
2019
29621254
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
PLoS One
2018
30459282
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.
Sci Signal
2018
29621254
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
PLoS One
2018
30459282
The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.
Sci Signal
2018
28817624
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma.
PLoS One
2017
28817624
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma.
PLoS One
2017
28883017
NFκB signaling in alveolar rhabdomyosarcoma.
Dis Model Mech
2017
28968964
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.
Oncotarget
2017
29100308
Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species.
Oncotarget
2017
28968964
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.
Oncotarget
2017
29100308
Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species.
Oncotarget
2017
28883017
NFκB signaling in alveolar rhabdomyosarcoma.
Dis Model Mech
2017
27255663
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Sci Rep
2016
28955934
Murine model of hepatic breast cancer.
Biochem Biophys Rep
2016
27255663
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Sci Rep
2016
28955934
Murine model of hepatic breast cancer.
Biochem Biophys Rep
2016
25939062
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
Nat Med
2015
25939062
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
Nat Med
2015
26151328
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
Nat Med
2015
26151328
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
Nat Med
2015
25117705
YAPping about differentiation therapy in muscle cancer.
Cancer Cell
2014
27057260
Group, One-on-One, or Internet? Preferences for Mindfulness Meditation Delivery Format and their Predictors.
Open Med J
2014
25117705
YAPping about differentiation therapy in muscle cancer.
Cancer Cell
2014
27057260
Group, One-on-One, or Internet? Preferences for Mindfulness Meditation Delivery Format and their Predictors.
Open Med J
2014
24274149
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma.
Skelet Muscle
2013
24274149
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma.
Skelet Muscle
2013
1 - 40 of 40
Column Actions
Search
Recommended Authors
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2014
Number of shared co-authors
3
Sachin A Kumar
University of Toronto
Career Start Year
2012
Number of shared co-authors
2
Daniel D'Andrea
Nottingham Trent University
Career Start Year
2010
Number of shared co-authors
0
Xin Wang
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year
2010
Number of shared co-authors
2
Duane G Currier
St. Jude Children's Research Hospital
Career Start Year
2008
Number of shared co-authors
1
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year
2008
Number of shared co-authors
4
Elizabeth Stewart
St Jude Children's Research Hospital
Career Start Year
2006
Number of shared co-authors
3
Xi Huang
The Hospital for Sick Children
Career Start Year
2005
Number of shared co-authors
2
Harish N Vasudevan
University of California San Francisco
Career Start Year
2005
Number of shared co-authors
0
Priscilla D Negraes
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year
2004
Number of shared co-authors
0
Daisuke Kawauchi
University of California-San Diego
Career Start Year
2003
Number of shared co-authors
1
Livia Garzia
The Research Institute of the McGill University Health Centre, McGill University
Career Start Year
2003
Number of shared co-authors
3
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
2002
Number of shared co-authors
2
Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2001
Number of shared co-authors
5
Eve Lapouble
Institut Curie
Career Start Year
2000
Number of shared co-authors
0
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year
1999
Number of shared co-authors
2
Clifton L Dalgard
Uniformed Services University of the Health Sciences
Career Start Year
1997
Number of shared co-authors
0
Michael And??ng
Karolinska Institutet
Career Start Year
1994
Number of shared co-authors
0
Philip J Ebert
Lilly Research Laboratories
Career Start Year
1993
Number of shared co-authors
0
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
1993
Number of shared co-authors
3
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
2
John Easton
St Jude Children's Research Hospital
Career Start Year
1991
Number of shared co-authors
3
Eric J Huang
University of California san francisco
Career Start Year
1990
Number of shared co-authors
0
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Career Start Year
1990
Number of shared co-authors
7
Poul H Sorensen
British Columbia Cancer Research Centre
Career Start Year
1989
Number of shared co-authors
7
Choh Yeung
Center for Cancer Research, National Cancer Institute
Career Start Year
1987
Number of shared co-authors
2
William A Weiss
University of California san francisco
Career Start Year
1985
Number of shared co-authors
3
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year
1985
Number of shared co-authors
7
Joshua B Rubin
Washington University in St. Louis
Career Start Year
1983
Number of shared co-authors
1
Scott L Pomeroy
Harvard Medical School
Career Start Year
1978
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Charles Keller
Children's Cancer Therapy Development Institute
Co-authored papers
16
Noah E Berlow
Children's Cancer Therapy Development Institute
Co-authored papers
11
Atiya Mansoor
Oregon Health & Science University
Co-authored papers
10
Jinu Abraham
Oregon Health & Science University
Co-authored papers
7
Joel E Michalek
University of Texas Health Science Center
Co-authored papers
6
Ranadip Pal
Texas Tech University
Co-authored papers
5
Martin Goros
University of Texas Health San Antonio
Co-authored papers
4
Lin Qi
Xiangya Hospital of Central South University
Co-authored papers
3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
3
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers
3
Xiao-Nan Li
Northwestern University
Co-authored papers
3
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
3
Megan M Cleary
Children's Cancer Therapy Development Institute
Co-authored papers
3
Paul T Spellman
Oregon Health & Science University Hospital.
Co-authored papers
2
Douglas S Hawkins
Co-authored papers
2
Marie-Anne Debily
Co-authored papers
2
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers
2
Javad Nazarian
USA University of Zurich
Co-authored papers
2
Eric H Raabe
Co-authored papers
2
Elaine Huang
Oregon Health and Science University, 3710 SW US Veterans Hospital Rd
Co-authored papers
2
Jack F Shern
Co-authored papers
2
Katherine E Warren
Co-authored papers
2
Maryam Fouladi
Co-authored papers
2
Marta M Alonso
CIMA-Universidad de Navarra
Co-authored papers
2
Jacques Grill
Co-authored papers
2
Carol J Bult
The Jackson Laboratory Cancer Center
Co-authored papers
2
Eric Wang
Co-authored papers
2
Michelle Monje
Co-authored papers
2
Nathalène Truffaux
Co-authored papers
2
Ken Kikuchi
Kyoto Prefectural University of Medicine
Co-authored papers
2
1 - 30